- 英文名称
- Rifaximin
- 分子式
- C43H51N3O11
- 分子量
- 785.89
- 中文别名
- 利福西亚胺; 4-脱氧-4'-甲基吡啶并[1',2'-1,2]咪唑并[5,4-C]利福素SV; 利福西明; (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(乙酰氧基)-5,6,21,23-四羟基-27-甲氧基-2,4,11,16,20,22,24,26-八甲基-2,7-(环氧十五烷[1,11,13]三亚氨基)苯并呋喃[4,5-e]吡啶[1,2-a]苯并咪唑-1,15(2H)-二酮; 2S-acetyloxy-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentoeleca(1,11,13)trienimino)benzofuro[4,5-e]pyride[1,2-a]benzimidazole-1,15(2h)-dione; XIFAXAN; normix; rifamycinl105; rifamycinl105sv; rifaxidin; RIFACOL; l105sv; l105; fatroximin; RIFAMIXIN; (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(Acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione
- 用途
- 用于对利福昔明敏感的病原菌引起的肠道感染（包括急性和慢性肠道感染、腹泻综合征、旅行者腹泻、小肠结肠炎等）；用于高氨血症（肝性脑病）的辅助治疗；用于预防胃肠道围手术期感染性并发症；对革兰阳性菌、革兰阴性菌（包括需氧菌和厌氧菌）有高度抗菌活性，可有效治疗多种消化道疾病。
